This inventor holds 1 USPTO granted patent. Top assignee: 89Bio, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Innovations by Leo Tseng in the Treatment of Severe Hypertriglyceridemia.
Introduction
Leo Tseng is an accomplished inventor based in San Francisco, CA. He has made significant contributions to the field of medical treatments, particularly focusing on severe hypertriglyceridemia. His innovative work has the potential to impact many lives.
Latest Patents
Leo Tseng holds a patent for "Compositions and methods of treatment for severe hypertriglyceridemia." This patent includes compositions, methods, and therapeutic regimens of mutant Fibroblast Growth Factor-21 (FGF-21) peptide conjugates aimed at treating this condition. His work in this area showcases his dedication to advancing medical science.
Career Highlights
Tseng is currently associated with 89Bio, Inc., where he continues to develop groundbreaking treatments. His expertise and innovative mindset have positioned him as a key player in the biotechnology sector.
Collaborations
Leo Tseng collaborates with Hank Mansbach, leveraging their combined knowledge and skills to further their research and development efforts.
Conclusion
Leo Tseng's contributions to the treatment of severe hypertriglyceridemia through his innovative patent highlight his role as a leading inventor in the medical field. His work continues to pave the way for advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile